the referees have rated the work as of poor technical quality and referees 1 and 2 the general interest as medium in the summary evaluation sheets returned with their reports Given these opinions and the fact that, due to pressure for space, EMBO reports can only invite revision of papers that receive enthusiastic support from a majority of referees, I am afraid that we cannot offer to publish your manuscript.
Thank you for your patience while your study has been under peer-review at EMBO reports. Please accept my apologies for the unusually long time that we have needed to make a decision regarding your study, as we received one of the referee reports only today. As you will see from the enclosed three reports, although the referees acknowledge the potential interest of the findings, they find the study is far from acceptable in our journal at this point. There are numerous technical concerns, and many issues regarding the conclusiveness of the data as well as its physiological relevance. In all, the referees have rated the work as of poor technical quality and referees 1 and 2 the general interest as medium in the summary evaluation sheets returned with their reports Given these opinions and the fact that, due to pressure for space, EMBO reports can only invite revision of papers that receive enthusiastic support from a majority of referees, I am afraid that we cannot offer to publish your manuscript.
We would, however, be willing to consider a new manuscript on the same topic that successfully addressed all of the referee concerns in full, if the outcome of such effort were support your current model. To be completely clear, I would like to stress that such a manuscript would be treated as a new submission and would be reviewed afresh. It would only be sent back to the referees if the findings were still novel at the time of submission and all referee concerns were fully and satisfactorily addressed through experimentation, so I would advise against this option unless your are willing to thoroughly rework your study.
I am sorry to bear these negative news, especially after such a protracted process, and hope that the referee comments are helpful in your continued work in this area.
Yours sincerely, Editor EMBO Reports
Referee #1:
The authors previously identified CKIP1 as a positive regulator of the Smurf1 E3 ligase. In this current manuscript, the authors used both biochemical and cellular approaches to demonstrate that CKIP1 could interact with the Rpt6 ATPase subunit of 19S regulatory particle of the proteasome, through which CKIP1 could govern the stability of Smurf1 as well as Smurf1 downstream substrates. The paper is clearly written, and for most part of the manuscript, the experiments are well thought-out and performed to address the points. However, there are several concerns that prevent this manuscript from being published in EMBO Report at its present form. Most importantly, the authors did not provide the biological significance for Rpt6-mediated regulation of the Smurf1 signaling pathway. In their previous paper, they showed that depletion of CKIP1 affects osteoblast differentiation process primarily by affecting Smurf1 activity. Thus it is critical to further show whether manipulating Rpt6 could also affect Smurf1 pathway to influence osteoblast differentiation. Furthermore, in some cases, critical controls are necessary to clarify their statements and further experimental evidences are required to support the proposed model. Below please find some specific comments.
1. Figure 1C , it will be nice to illustrate the interaction between endogenous CKIP1 and endogenous Rpt6. 2. Figure S1 and Table 1 . Through mass spect analysis of CKIP-associated proteins, the authors identified a long list of 26S proteasome subunits including Rpt2, Rpt3 and Rpn10. However, later co-immunoprecipitation expression experiment showed that CKIP1 only interacts with Rpt1 and Rpt6 but not other components. Although the authors claimed that CKIP1 may only interacts directly with Rpt1 and Rpt6, but indirectly with other components, experimental evidence is required to support this notion. GST-pull down assays should be performed to show that CKIP1 only directly interacts with Rpt1 and Rpt6. Furthermore, it is interesting to note that later on the authors showed that Smurf1 could interact with Rpt6 in co-IP but not in GST-pull down assays, and CKIP serves as a bridging adaptor to mediate Smurf1/Rpt6 interaction. Thus, it is difficult to understand why under co-IP conditions, endogenous Rpt6 cannot serve as bridging module to mediate the interaction between CKIP and other 26S component Rpt2 and Rpt3? If not, whether overexpression of Rpt6 could enhance the interaction between CKIP and Rpt2 and/or Rpt3. 3. Figure 1 , a related question, what is the important role of CKIP1 interaction with Rpt1 in addition to Rpt6? 4. Figure 3B -C, the brackets for these two figure panels are mislabeled. 5. Figure 3C , as the GST-pull down results are different from the co-IP experiments in assessing which domain of CKIP is critical to mediate the interaction with CKIP1, it is critical to repeat the interaction mapping between Rpt6 and CKIP1 truncation in the co-IP setting. Furthermore, it is also important to map the critical domain within CKIP1 to interact with Rpt1. 6. Figure 4A , as Rpt6 is a critical component of the 19S regulatory particle of the proteasome, it is reasonable to assume that depletion of Rpt6 will lead to stabilization of various unstable proteins. Therefore, in addition to Smurf1, other proteins such as p27, cyclin E and cyclin B should be included as negative controls to show whether depletion of Rpt6 only affects Smurf1, or affects a wide spectrum of protein half-lives. In addition, to build up a causal relationship between Rpt6 and Smurf1, it is critical to re-introduce WT-Rpt6 and Rpt6 (151-406) that does not interact with CKIP1, into Rpt6-depleted cells. It is anticipated that WT, but not mutant Rpt6 should restore Smurf1 levels. 7. Figure 4B , as this work primarily addresses the importance of Rpt6 in regulating Smurf1 downstream substrates, in addition to monitoring the steady state levels of various Smurf1 substrates, pulse chase experiments should be performed to assess the changes in their half-lives as read-outs of Smurf1 activity changes. 8. Figure 4 , siRpt1 and SiRpt1/siRpt6 should be performed to see whether there are synergistic roles between Rpt1 and Rpt6 in regulating Smurf1, and more importantly, in governing the downstream biological outputs including osteoblast differentiation.
9. Figure 4 , the role of CKIP1 as an adaptor to recruit ubiquitinated Smurf1 and its substrates to 26S proteasome should be further evaluated by double depletion experiment. It will be important to examine whether there is no further stabilization of Smurf1 and its substrates when Rpt6 is depleted in CKIP1-/-MEFs or CKIP1 knocking down cells. 10. Figure 4 , according to the author's model, CKIP1 facilitates Smurf1 auto-ubiquitination and its substrates' turnover through two possible mechanisms, either by inducing Smurf1-substrate interaction or by recruiting them to the 26S proteasome via Rpt6 subunit. Thus it will be nice to dissect these two distinct mechanisms by re-introducing different CKIP1 mutants to CKIP1-depleted cells. The author will expect to see the re-introducing of N-terminal CKIP1 will only partially rescue the CKIP1 depletion-caused Smurf1 stabilization but the re-introducing of LZ domain of CKIP1, which cannot bind Smurf1, will not affect Smurf1 levels.
Referee #2:
The manuscript titled "CKIP-1 couples Smurf1 ........" by Wang et al details primarily binding experiments that map domains of interaction between Rpt6 and CKIP-1. Rpt6 was identified as a binding partner of CKIP-1 by two hybrid, and mass spec analysis. Prior studies by the authors had identified the Smurf1 ubiquitin ligase as a CKIP-1 interacting protein. In the current study, the authors determine that Rpt6 does not interact with Smurf1 in vitro, but in vivo the interaction was shown to be mediated in part by CKIP-1. Functional consequences of perturbing these interactions were explored in Figure 4 .
Major Comments: 1. It is unclear at present if Rpt6 is interacting with CKIP1 in vivo as part of an intact 26S proteasome, or a 19S or Base sub-particle. The mass spec data identifies proteasomal subunits, but immunoblotting data limits interaction of CKIP-1 to Rpt6 and Rpt1. Intact 26S proteasome assemblies can be immunoprecipitated from lysates by using Mg-ATP in the buffers; from the very limited Methods section, there is nothing to suggest that nucleotides were included. 2. Additionally, the proteasome is abundant and good antibodies to subunits are available from researchers, as well as commercially. The authors should immunoblot for endogenous proteasome subunits in their CoIP experiments, rather than transfecting, and overproducing single subunits. 3. In Fig. 4F , the degradation of endogenous Smurf1 is assayed. When Rpt6 is expressed ectopically, the half-life of Smurf1 is further decreased. This suggests that either 26S proteolytic activity is limiting in these cells, or that Rpt6 functions as an adaptor, separate from the 26S entity. The latter hypothesis would be predicted because overproducing one subunit of a hexamer is unlikely to cause an overall increase in proteolytic capacity. This issue can be addressed by measuring peptidase activity from un-transfected, and Rpt6-transfected cells. Or by immunoblotting for Ub conjugate levels. This would shed further mechanistic insight. 4. As mentioned above, Method descriptions are minimal. Figure Legends are equally cryptic. For example, in Figures 4A, 4C , 4D, increasing concentrations of CKIP-1 or Rpt6 are being transfected. At the very least, the concentation range of the plasmids should be given for reproducibility. In Fig.  4A , Lanes 1 and 4 are contrasted for Smurf1 levels. However, the levels of CKIP1 are nearly identical between Lanes 3 and 4. It would be good to state in the figure legend whether this experiment is representative of x # of experiments. Minor points: 1. The Abstract states "Depletion of CKIP-1 significantly reduces the affinity of Smurf1 and Rpt6". This statement implies that binding constants were measured. Instead, the authors are referring to their immuno-precipitation data. The abstract should be reworded to include some of their functional data from Fig. 4 . 2. The text is unclear due to grammatical errors and improper sentence construction.
Referee #3:
The goal of the manuscript under review is to demonstrate a novel mechanism of targeting of a set of proteins for degradation by the proteasome. In this mechanism CKIP-1 serves as a bridging adaptor that binds to the proteasome and to the ubiquitin protein ligase Smurf1, which in turn binds to its substrates. These interactions lead to the degradation of Smurf1 and its substrates.
I think that the proposed mechanism is quite interesting but the manuscript does not yet provide convincing experimental evidence in its support.
The manuscript provides good evidence for the interaction between the proteasome, CKIP-1, and Smurf1 and maps the interactions to specific domains within the proteins. As the authors report, they had previously defined different domains for the interaction of the three components but they provide a plausible explanation why the current manuscript comes to different conclusions. One concern here is that in some experiments the interaction between CKIP-1 and the proteasome does not map to a single subunit as would be expected for a specific adaptor protein. This observation should be discussed.
Most importantly, the relevance of the interactions to degradation is poorly supported and this part of the manuscript would have to be very significantly improved before publication can be considered. My biggest concern regards the design of the experiments purported to show that the interaction CKIP-1 and the proteasome subunit Rpt6 is required for degradation of Smurf1. In these experiments the expression of Rpt6 is up and down regulated and corresponding effects on Smurf1 degradation are determined. Since Rpt6 is a key stoichiometric component of the proteasome, it is not surprising that reducing its expression will compromise proteasome function. This observation cannot be taken as evidence for a specific role of Rpt6 in the process under investigation here. Furthermore, I am surprised that overexpression of Rpt6 enhances degradation of Smurf1. If anything, I would have expected it to decrease degradation of Smurf1 as excess Rpt6 that cannot be integrated into proteasome particles would compete CKIP-1 and Smurf1 away from the proteasome.
Other suggestions: I recommend explaining the motivation behind the proposed mechanism better. Several times, the manuscript raises the question as to how Smurf1 and its substrates are degraded by the proteasome and then goes on to discuss how all the substrates under discussion are ubiquitinated by Smurf1 and that there are at least five different ubiquitin receptors. Why additional targeting factors are required?
I recommend providing fuller background and to cite some of the literature on proteasome targeting adaptors.
Many of the figures are difficult to follow and the labeling could be improved.
Resubmission 25 June 2012
Responses to the Editor:
Comments: Thank you for your patience while your study has been under peer-review at EMBO reports. Please accept my apologies for the unusually long time that we have needed to make a decision regarding your study, as we received one of the referee reports only today. As you will see from the enclosed three reports, although the referees acknowledge the potential interest of the findings, they find the study is far from acceptable in our journal at this point. There are numerous technical concerns, and many issues regarding the conclusiveness of the data as well as its physiological relevance. In all, the referees have rated the work as of poor technical quality and referees 1 and 2 the general interest as medium in the summary evaluation sheets returned with their reports. Given these opinions and the fact that, due to pressure for space, EMBO reports can only invite revision of papers that receive enthusiastic support from a majority of referees, I am afraid that we cannot offer to publish your manuscript. We would, however, be willing to consider a new manuscript on the same topic that successfully addressed all of the referee concerns in full, if the outcome of such effort were support your current model. To be completely clear, I would like to stress that such a manuscript would be treated as a new submission and would be reviewed afresh. It would only be sent back to the referees if the findings were still novel at the time of submission and all referee concerns were fully and satisfactorily addressed through experimentation, so I would advise against this option unless your are willing to thoroughly rework your study. proteasome. We hope the modified manuscript will meet the standard for publication in the EMBO Reports.
Response (R)
:
Responses to Reviewer #1:
Comments: The authors previously identified CKIP1 as a positive regulator of the Smurf1 E3
ligase. In this current manuscript, the authors used both biochemical and cellular approaches to demonstrate that CKIP1 could interact with the Rpt6 ATPase subunit of 19S regulatory particle of the proteasome, through which CKIP1 could govern the stability of Smurf1 as well as Smurf1 downstream substrates. The paper is clearly written, and for most part of the manuscript, the experiments are well thought-out and performed to address the points. However, there are several concerns that prevent this manuscript from being published in EMBO Report at its present form.
Most importantly, the authors did not provide the biological significance for Rpt6-mediated regulation of the Smurf1 signaling pathway. In their previous paper, they showed that depletion of CKIP1 affects osteoblast differentiation process primarily by affecting Smurf1 activity. Thus it is critical to further show whether manipulating Rpt6 could also affect Smurf1 pathway to influence osteoblast differentiation. Furthermore, in some cases, critical controls are necessary to clarify their statements and further experimental evidences are required to support the proposed model. Below please find some specific comments. Q2: Figure S1 and Table 1 . Through mass spect analysis of CKIP-associated proteins, the authors Q4: Figure 3B -C, the brackets for these two figure panels are mislabeled. Fig. 3B and 3D . We carefully checked the labeling of these two panels and have made sure they are correct.
R: Previous Figures 3B-C are now
Q5: Figure 3C , as the GST-pull down results are different from the co-IP experiments in assessing which domain of CKIP is critical to mediate the interaction with CKIP1, it is critical to repeat the interaction mapping between Rpt6 and CKIP1 truncation in the co-IP setting. Furthermore, it is also important to map the critical domain within CKIP1 to interact with Rpt1. For the case of Rpt1, as we described above, CKIP-1 did not interact with Rpt1 directly, so we did not perform further mapping analysis. Figure 4A , as Rpt6 is a critical component of the 19S regulatory particle of the proteasome, it is reasonable to assume that depletion of Rpt6 will lead to stabilization of various unstable proteins.
Q6:
Therefore, in addition to Smurf1, other proteins such as p27, cyclin E and cyclin B should be included as negative controls to show whether depletion of Rpt6 only affects Smurf1, or affects a wide spectrum of protein half-lives. In addition, to build up a causal relationship between Rpt6 and Smurf1, it is critical to re-introduce WT-Rpt6 and Rpt6 (151-406) that does not interact with CKIP1, into Rpt6-depleted cells. It is anticipated that WT, but not mutant Rpt6 should restore Smurf1 levels. (Fig. 5G) . Re-introduction of CKIP-1 leucine zipper (338-373), which cannot bind to Smurf1, also had no effect on Smurf1 levels (Fig. 5G) showed that CKIP-1 uniquely recognized Rpt6 but not Rpt1-5 (Fig. 1C) . Second, Co-IP assays showed that the interaction between endogenous Rpt6 and endogenous CKIP-1 was detectable whereas the interaction between Rpt1, Rpt2, or Rpt3 with CKIP-1 was undetectable (Fig. 1F) .
Even in the presence of ectopic Rpt6, the interaction between CKIP-1 and Rpt1, Rpt2, Rpt3, Rpt5 was either very weak (for Rpt1) or undetectable (for Rpt2, 3, 5) (Fig. 1G) . Third, an in vitro proteasome activity assay in which the cell lysate expressed ectopic Rpt6 or other Rpt subunits clearly showed that Rpt6 expression led to a three-fold increase in proteasome activity, whereas the expression of other Rpt subunits caused moderate or weak effects (Fig.   5A ). This result suggests that in addition to the component of the intact proteasome, free Rpt6 also plays a regulatory role on the assembly and activation of the proteasome. Therefore, we proposed that CKIP-1 interacted with free Rpt6 and enhanced the activity of Rpt6 to elevate the whole activity of 26S proteasome.
Q2:
Additionally, the proteasome is abundant and good antibodies to subunits are available from researchers, as well as commercially. The authors should immunoblot for endogenous proteasome subunits in their CoIP experiments, rather than transfecting, and overproducing single subunits.
R: Thanks, we bought five other antibodies each recognizes Rpt1-5. They were used in the experiments shown in Fig. 1F, 1G, 5D , 5E. The results of Co-IP experiments (Fig. 1F, 1G) are described above. (P.S. The Rpt4 antibody did not work well in the immunoblotting, so we showed the results of Rpt1, 2, 3, 5 and 6 in our manuscript) Q3: In Fig. 4F , the degradation of endogenous Smurf1 is assayed. When Rpt6 is expressed ectopically, the half-life of Smurf1 is further decreased. This suggests that either 26S proteolytic activity is limiting in these cells, or that Rpt6 functions as an adaptor, separate from the 26S entity.
The latter hypothesis would be predicted because overproducing one subunit of a hexamer is unlikely to cause an overall increase in proteolytic capacity. This issue can be addressed by measuring peptidase activity from un-transfected, and Rpt6-transfected cells. Or by immunoblotting for Ub conjugate levels. This would shed further mechanistic insight.
R:
We performed the proteasome peptidase activity assay as the reviewer recommended. The peptidase activity of the un-transfected cell lysate can be easily detected whereas treatment of MG132, the proteasome inhibitor, resulted in the lost of the peptidase activity (Fig. 5A , columns 2-3). When Rpt6 was overexpressed, the peptidase activity increased to three folds of the un-transfected group (Fig. 5A, column 9) . Also, the MG132 treatment blocked the peptidase activity (column 10). Expression of Rpt1-Rpt5 resulted in relatively moderate effects (columns 4-8), compared to that of Rpt6, suggesting that Rpt6 might have a special regulatory effect on the intact proteasome activity. These data support the latter hypothesis that Rpt6 functions as an adaptor, separate from the 26S entity, as the reviewer predicted. At the very least, the concentation range of the plasmids should be given for reproducibility. In 
Q2:
The text is unclear due to grammatical errors and improper sentence construction.
R: We apologize for the grammatical errors and improper sentence construction in the manuscript. The current revised manuscript has been edited by an expert company, American
Journal Experts (http://www.journalexperts.com), and we therefore believe the grammatical errors have been avoided.
Response to Reviewer #3:
Q1: The manuscript provides good evidence for the interaction between the proteasome, CKIP-1, and Smurf1 and maps the interactions to specific domains within the proteins. As the authors report, they had previously defined different domains for the interaction of the three components but they provide a plausible explanation why the current manuscript comes to different conclusions. One concern here is that in some experiments the interaction between CKIP-1 and the proteasome does not map to a single subunit as would be expected for a specific adaptor protein. This observation should be discussed. R: As we described in the response to Reviewer #1, we provided more evidence to make the conclusion that CKIP-1 specifically recognizes Rpt6 among the proteasome subunits. We
performed in vitro GST pull-down assays to test the possible interaction of CKIP-1 with each
Rpt protein of the base sub-particle. The data showed clearly that only Rpt6 interacted with CKIP-1 but all other five Rpt proteins did not (Fig. 1C) . Co-IP assays showed that endogenous CKIP-1 was co-immunoprecipitated with Rpt6, but was not with Rpt1, Rpt2, and Rpt3 ( (Fig. 1D) . We then made the conclusion that CKIP-1 specifically recognized Rpt6 among 19S regulatory particle.
Q2:
Most importantly, the relevance of the interactions to degradation is poorly supported and this part of the manuscript would have to be very significantly improved before publication can be considered. My biggest concern regards the design of the experiments purported to show that the interaction CKIP-1 and the proteasome subunit Rpt6 is required for degradation of Smurf1. In these experiments the expression of Rpt6 is up and down regulated and corresponding effects on Smurf1 degradation are determined. Since Rpt6 is a key stoichiometric component of the proteasome, it is not surprising that reducing its expression will compromise proteasome function. This observation cannot be taken as evidence for a specific role of Rpt6 in the process under investigation here. By contrast, this effect was not detectable with the CKIP-1 ΔLZ mutant, which lacks the Rpt6-binding leucine zipper (Fig 5G) . The re-introduction of the CKIP-1 leucine zipper (338-373), which cannot bind to Smurf1, also had no effect on Smurf1 levels (Fig. 5G) We deeply hope that these modifications will satisfy you and all of the referees and that the current manuscript will be considered for publication in your journal. Thank you very much in advance for your attention to our work. We look forward to your response. Thank you for the resubmission of your manuscript to EMBO Reports. I first must apologize for the great delay in processing your manuscript, which is due to the fact that we have only now received the full set of referee reports that I copy below.
As you will see, all referees appreciate your efforts to address their comments and agree that the manuscript has been greatly improved. Referee #2 and Referee #3 both support publication of your work in EMBO Reports, but as Referee #3 suggests with minor modifications in the discussion. Referee #1 however is still concerned about the physiological role of CKIP-1 mediated degradation of Smurf-1 in osteoblast differentiation. Given that the other two referees do not raise this specific concern, we have decided that you do not need to address it for publication of the study in EMBO Reports. Given these evaluations I would therefore like to invite you to revise the manuscript along the lines suggested by referee #3. I assure you this final peer-review process will be faster than before.
Please note that acceptance of the manuscript will depend on a positive outcome of a second round of review and that it is EMBO reports policy to allow a single round of revision only. Therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Also, the revised manuscript may not exceed 30,000 characters (including spaces, references, and figure legends) and 5 figures plus 5 supplementary figures, which should directly relate to the corresponding main figure. I would also like to remind you that p-values, error bars and the number of experiments performed (n) must be defined in the relevant figure legends.
When submitting your revised manuscript, please include:
A Microsoft Word file of the manuscript text, editable high resolution TIFF or EPS-formatted figure files, a separate PDF file of any Supplementary information (in its final format) and a letter detailing your responses to the referee comments. Please also include a two sentence-summary of the manuscript that will appear online on our webpage in case of acceptance of the study for publication.
We would also welcome the submission of cover suggestions, or motifs to be used by our Graphics Illustrator in designing a cover.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case."
I look forward to seeing a revised version of your manuscript when it is ready. Again, please accept our sincerest apologies for the delay in the review of your manuscript.
Yours sincerely, Editor EMBO reports Referee #1
The authors have spent serious efforts in addressing the outstanding concerns raised up in the last round of review. As a result, the manuscript has been significantly improved. I only have some remaining concerns related to the physiological role of CKIP1-mediated degradation of Smurf1, especially for its effects in osteoblast differentiation, which the authors failed to address in this round of revision. These critical points should be fully addressed before publication of this study at EMBO Reports.
In the revised manuscript, the authors have incorporated newly generated results to show that overexpression of Rpt6 significantly enhance the ability of CKIP to suppress the BMP-Luc reporter activity (Fig. 4F ). It will be nice for the authors to further show whether depletion of endogenous Rpt6 also affects BMP-reporter activity in part through regulation of Smurf1 (which can be addressed by Smurf1/Rpt6 double depletion). More importantly, it will be nice for the authors to carry out more functional assays used in their previous publications to show that depletion of endogenous Rpt6, which stabilizes Smurf1 as well as Smurf1 substrates, could activate osteoblast differentiation. Furthermore, it is critical for the authors to examine whether additional depletion of Smurf1 could restore the obsteobloast differentiation defects in Rpt6-depleted cells. As loss of Rpt6 leads to reduced Smurf1-dependent destruction of its downstream substrates, indicating an inactive form of Smurf1 in Rpt6-depleted cells, it is anticipated that additional depletion of Smurf1 might not have major effects in Rpt6-depleted cells. Conversely, it is also critical for the authors to show that overexpression of Rpt6 could suppress osteoblast differentiation, presumably by activating the Smurf1 E3 ligase activity towards its downstream targets. This reviewer believes that these functions assays will serve to unify these biochemical results with the downstream Smruf1 signaling pathway as well as the subsequent biological effects, thereby providing strong support for the critical physiological importance of CKIP/Rpt6-depednent regulation of Smurf1 stability and its downstream signaling pathways.
Referee #2
The authors have satisfactorily answered the questions raised by me.
Referee #3
I am impressed with the great effort the authors have put into their response to the referee reports. They have performed difficult and complex experiments and thus some of the data described in the manuscript, by the very nature of the experiments, have to remain ambiguous. However, the body of experimental evidence taken together convincingly shows that CKIP-1 stimulates degradation of Smurf1 and its substrates. Their is good evidence that CKIP-1 does so by functioning as a proteasome adaptor acting through the Rpt6 subunit.
I remain somewhat concerned that one aspect of the mechanism invoked in the manuscript is not entirely intuitive to the usual mechanistic thinking about enzyme action. In the simplest mechanism for Rpt6 in Smurf1 degradation, it acts in its established location incorporated into the ATPase ring of the proteasome cap. There is serves as a docking site for CKIP-1, allowing the latter to act as a substrate adaptor for the proteasome. This is a clean and plausible mechanism. The unexpected observation is that significant overexpression of Rpt6 stimulates Smurf1 degradation further. In the simplest mechanism excess free Rpt6 (not incorporated into the proteasome) would compete CKIP-1 away from the proteasome and therefore inhibit Smurf degradation. The manuscript goes on to suggest that free cellular Rpt6 somehow stimulates proteasome activity broadly against other substrates. The mechanism of this effect is not clear at all and this is unsatisfactory to me.
There are other observations that are not entirely straightforward. For example, I am confused that immunoprecipitation from cells with endogenous proteasome subunit levels shows clear and clean specificity of the interaction between CKIP-1 and Rpt6. The ATPase ring in the proteasome is quite stable and I would have expected it to act as one unit in these experiments. (In the over expression experiments, the specificity is expected and strengthens the conclusions).
However, biology often does not conform to our simplest models and I am ready to just accept these various unexpected effects as an empirical observation that we will understand in the future. I do propose that the authors do discuss the puzzling nature of some of the observations explicitly and it may be good to invoke plausible mechanism (could Rpt6 overexpression affect assembly of incomplete assembly intermediates or affect gene expression of proteasome subunits in some way?)
In summary, the paper describes a novel, significant, and important phenomenon that will be of interest to the readers of EMBO Reports. I support publication in EMBO Reports after minor modifications to the discussion.
Revision -authors' response 24 August 2012
Comments: As you will see, all referees appreciate your efforts to address their comments and agree that the manuscript has been greatly improved. Referee #2 and Referee #3 both support publication of your work in EMBO Reports, but as Referee #3 suggests with minor modifications in the discussion. Referee #1 however is still concerned about the physiological role of CKIP-1 mediated degradation of Smurf-1 in osteoblast differentiation. Given that the other two referees do not raise this specific concern, we have decided that you do not need to address it for publication of the study in EMBO Reports. Given these evaluations I would therefore like to invite you to revise the manuscript along the lines suggested by referee #3. I assure you this final peer-review process will be faster than before.
Response (R):
We carefully read your letter and the three referees' comments. First of all, we want to say thanks to all of the referees. We appreciate your kind support on our manuscript.
According to your suggestion, we carefully modified the Discussion and added more descriptions and statements to fully address Referee #3's question. In addition, about referee #1's comments, we noted that besides the question on osteoblast differentiation, he/she also suggested an experiment "In the revised manuscript, the authors have incorporated newly generated results to show that overexpression of Rpt6 significantly enhance the ability of CKIP to suppress the BMP-Luc reporter activity (Fig. 4F ). It will be nice for the authors to further show whether depletion of endogenous Rpt6 also affects BMP-reporter activity in part through regulation of Smurf1 (which can be addressed by Smurf1/Rpt6 double depletion)."
We appreciate this is a good suggestion for us to improve the manuscript. So we decide to perform this experiment and provide new data in the revised version now. We hope the modified manuscript will meet the standard for publication in the EMBO Reports.
Responses to Referee #1:
Question: In the revised manuscript, the authors have incorporated newly generated results to show that overexpression of Rpt6 significantly enhance the ability of CKIP to suppress the BMP-Luc reporter activity (Fig. 4F ). It will be nice for the authors to further show whether depletion of endogenous Rpt6 also affects BMP-reporter activity in part through regulation of Smurf1 (which can be addressed by Smurf1/Rpt6 double depletion).
R: Many thanks for your valuable suggestion on our manuscript. Consistent with the observation of Rpt6 overexpression (Fig. 4F) , depletion of endogenous Rpt6 by RNAi resulted in the increase of BRE-Luc activity (Fig. 4G ). To explore whether the effect of Rpt6 on BRELuc was in part through regulation of Smurf1, we performed Smurf1/Rpt6 double depletion.
We found that the double depletion had a similar effect to the single depletion of either Rpt6 or Smurf1 (Fig. 4G) , suggesting that Rpt6 and Smurf1 regulated BMP signaling through the same mechanism.
Responses to Referee #2:
Comment: The authors have satisfactorily answered the questions raised by me.
R: Many thanks for your kind support.
Responses to Referee #3:
Comments: I remain somewhat concerned that one aspect of the mechanism invoked in the manuscript is not entirely intuitive to the usual mechanistic thinking about enzyme action. In the simplest mechanism for Rpt6 in Smurf1 degradation, it acts in its established location incorporated into the ATPase ring of the proteasome cap. There is serves as a docking site for CKIP-1, allowing the latter to act as a substrate adaptor for the proteasome. This is a clean and plausible mechanism.
The unexpected observation is that significant overexpression of Rpt6 stimulates Smurf1 degradation further. In the simplest mechanism excess free Rpt6 (not incorporated into the proteasome) would compete CKIP-1 away from the proteasome and therefore inhibit Smurf degradation. The manuscript goes on to suggest that free cellular Rpt6 somehow stimulates proteasome activity broadly against other substrates. The mechanism of this effect is not clear at all and this is unsatisfactory to me.
In summary, the paper describes a novel, significant, and important phenomenon that will be of interest to the readers of EMBO Reports. I support publication in EMBO Reports after minor modifications to the discussion. proteasome. This conclusion was based on the following evidences. First, in vitro binding assays showed that CKIP-1 uniquely recognized Rpt6 but not Rpt1-5 (Fig. 1C) . Second, Co-IP assays showed that the interaction between endogenous Rpt6 and endogenous CKIP-1 was detectable whereas the interaction between Rpt1, Rpt2, or Rpt3 with CKIP-1 was undetectable (Fig. 1F) . Even in the presence of ectopic Rpt6, the interaction between CKIP-1 and Rpt1, Rpt2, Rpt3, Rpt5 was either very weak (for Rpt1) or undetectable (for Rpt2, 3, 5) (Fig. 1G) . Third, an in vitro proteasome activity assay in which the cell lysate expressed ectopic Rpt6 or other Rpt subunits clearly showed that Rpt6 expression led to a three-fold increase in proteasome activity, whereas the expression of other Rpt subunits caused moderate or weak effects (Fig. 5A) . This result suggests that in addition to the component of the intact proteasome, free Rpt6 also plays a regulatory role on the assembly and activation of the proteasome. Therefore, we proposed that CKIP-1 interacted with free Rpt6 and enhanced the activity of Rpt6 to elevate the whole activity of 26S proteasome. Future studies should investigate the underlying mechanism by which Rpt6 regulates the entire proteasome activity. For example, could Rpt6 overexpression affect assembly of incomplete assembly intermediates or affect gene expression of proteasome subunits in some way?
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